--(BUSINESS WIRE)--Fresenius Kabi leaders Steve Nowicki, Dr. Michael Schoenhofen and John Ducker join Mayor Ron Serpico of Melrose Park, Illinois at a groundbreaking ceremony to begin work for the expansion of Fresenius Kabi’s pharmaceutical operations in Melrose Park, Illinois. The company is a leading provider in the U.S. of generic sterile injectable medicines.
Fresenius Kabi Breaks Ground on $250 million Expansion of Pharmaceutical Manufacturing Site in Illinois
(from left to right) Fresenius Kabi leaders Steve Nowicki, Dr. Michael Schoenhofen and John Ducker join Mayor Ron Serpico of Melrose Park, Illinois at a groundbreaking ceremony to begin work for the expansion of Fresenius Kabi’s pharmaceutical operations in Melrose Park, Illinois. The company is a leading provider in the U.S. of generic sterile injectable medicines. (Photo: Business Wire)
-
(from left to right) Fresenius Kabi leaders Steve Nowicki, Dr. Michael Schoenhofen and John Ducker join Mayor Ron Serpico of Melrose Park, Illinois at a groundbreaking ceremony to begin work for the expansion of Fresenius Kabi’s pharmaceutical operations in Melrose Park, Illinois. The company is a leading provider in the U.S. of generic sterile injectable medicines. (Photo: Business Wire)
-
(from left to right) Fresenius Kabi leaders Steve Nowicki, Dr. Michael Schoenhofen and John Ducker join Mayor Ron Serpico of Melrose Park, Illinois at a groundbreaking ceremony to begin work for the expansion of Fresenius Kabi’s pharmaceutical operations in Melrose Park, Illinois. The company is a leading provider in the U.S. of generic sterile injectable medicines. (Photo: Business Wire)
-
Contacts
Matt Kuhn
Fresenius Kabi
847-550-5751
matt.kuhn@Fresenius-kabi.com
